About Beyond Gender: Ideas and Evidence
The ideas behind the podcast
This site follows the ideas that run through the Beyond Gender podcast: how gender identity became an organising principle of Western culture in a single generation, and what the evidence says about the results.
Why a site about ideas
A podcast moves fast. A guest makes a point, the conversation moves on, and the point is gone. This site slows things down. It takes the recurring themes of Beyond Gender, gender as a cultural shift, the behaviour of institutions under pressure, the difference between affirmation and therapy, the meaning of evidence, and lays them out as dossiers that can be read, checked and argued with.
How the dossiers are built
Each dossier starts with the facts and dates, then sets out the main positions, then marks interpretation clearly as interpretation. Sources are linked, and wherever possible they are primary: judgments, systematic reviews, official guidance, the original study rather than a newspaper report of it. A timeline places the key events in order. A sources page collects the documents in one place.
The point of view
The site is gender-critical. It treats sex as a biological category, gender identity as a belief about oneself that deserves respect but not medical deference, and children as people who cannot consent to lifelong interventions. It also treats disagreement as normal. Readers who arrive convinced of the opposite will find the arguments they oppose stated as fairly as the site can manage.
Who publishes it
Beyond Gender: Ideas and Evidence is published by Genspect, the international organisation founded in Ireland in 2021 to promote evidence-based approaches to gender distress. The podcast whose ideas this site follows is hosted by Stella O'Malley, Mia Hughes and Dr Bret Alderman.
Ideas on evidence and clinics
The evidence on youth gender medicine
“Puberty blockers” is the common name for gonadotrophin-releasing hormone agonists, or GnRH agonists. In this context, they are prescribed to suppress the hormonal processes of puberty. “Cross-sex hormones” is a widely used but contested term; clinical documents more often use “masculinising and feminising hormones” or “gender-affirming hormones”. These include testosterone for females and oestrogen-based treatment for males, sometimes alongside medicines that suppress testosterone.
Gender clinics and the whistleblowers
Public debate about paediatric gender medicine often treats “the clinic” as a single, unified actor. The documentary record tells a more complicated story. At several services, staff members, former staff members and safeguarding professionals reported concerns about assessment, consent, mental-health complexity, data collection, follow-up and whether clinical disagreement could safely be voiced. These reports do not all have the same status. Some are findings in employment tribunals; some are sworn allegations; some are institutional reviews; and some are professional concerns communicated co